Valpimo 133.5mg/58mg Tablet CR

Overview Valpimo 133.5mg/58mg Tablet CR

Epilegard CR 133.5mg/58mg tablets combine two medications to manage epilepsy, a neurological condition characterized by recurring seizures. This dual-action formulation regulates aberrant brain activity, promoting nerve relaxation and seizure prevention. Epilegard CR should be taken with food; dosage will be determined by your physician, potentially increasing gradually until your seizures are controlled. Therapeutic effects may take weeks to manifest; consistent use is crucial. Discontinuation, except under medical supervision, may trigger increased seizure frequency or worsen any coexisting bipolar disorder. Common side effects include nausea and tremors; less frequent but possible effects are vomiting, headache, hepatic dysfunction, and upper abdominal discomfort. While most side effects resolve spontaneously, persistent or bothersome effects warrant immediate medical attention; management strategies may be available. Prior to initiating treatment, disclose any kidney or liver disease, meningitis, depression, or suicidal ideation. Inform your physician of all concurrent medications, including contraceptives, as interactions are possible. While use during pregnancy or breastfeeding is possible if deemed essential by your doctor, dosage adjustments might be necessary. Refrain from driving or cycling if drowsiness or dizziness occur. Regular blood tests may be required to monitor treatment efficacy. Alcohol consumption should be avoided as it may exacerbate certain side effects. Weight gain is a potential consequence; maintain a healthy diet, limit high-calorie snacks, and incorporate regular exercise. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts or actions to your doctor promptly.

Uses of Valpimo 133.5mg/58mg Tablet CR

Seizure disorder

Major Benefits of Valpimo 133.5mg/58mg Tablet CR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Valpimo 133.5mg/58mg CR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Valpimo 133.5mg/58mg Tablet CR:

• Nausea
• Tremors

How to use Valpimo 133.5mg/58mg Tablet CR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Valpimo 133.5mg/58mg Controlled-Release tablets should be administered with a meal.

How Valpimo 133.5mg/58mg Tablet CR works:

Controlled-release Valpimo tablets (133.5mg/58mg) contain sodium valproate and valproic acid, both anticonvulsant medications.

What if you forget to take Valpimo 133.5mg/58mg Tablet CR :

Should you forget a Valpimo 133.5mg/58mg CR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.